CytoDyn (CYDY) Amortization of Deferred Charges (2011 - 2025)
CytoDyn (CYDY) recorded Amortization of Deferred Charges of $325,000 in fiscal Q2 2026 (quarter ended Nov 30, 2025), up 187.6% from $113,000 a year earlier.
Powered by 
Analysis
CytoDyn (CYDY) Amortization of Deferred Charges (2011 - 2025) Analysis & Trends
On a TTM basis, CytoDyn's Amortization of Deferred Charges came in at $607,000 as of Nov 30, 2025, down 21.4% year-over-year; for FY2025 (ended May 31, 2025), it was $407,000, down 62.2% from FY2024.
- Annual Amortization of Deferred Charges has declined for four straight fiscal years, with a five-year compound annual growth rate of -24.4% (FY2020 to FY2025).
- Across earlier fiscal years, Amortization of Deferred Charges came in at $1.08 million in FY2024 (-49.4%), $2.13 million in FY2023 (-28.1%), $2.96 million in FY2022 (-17.6%) and $3.59 million in FY2021 (+118.3%).
- The fiscal Q2 2026 figure is the highest quarterly Amortization of Deferred Charges since fiscal Q3 2024.
- On a year-over-year basis, Amortization of Deferred Charges rose in 1 of the last seven quarters, with an average decline of 17.7%.
- Peak year-over-year performance for Amortization of Deferred Charges in the last five years was growth of 386.9% in fiscal Q4 2021, against a decline of 75.5% in fiscal Q2 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | CytoDyn | 355.23 Mn | 306.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2025 | 325,000.00 |
| May 31, 2025 | 59,000.00 |
| Feb 28, 2025 | 110,000.00 |
| Nov 30, 2024 | 113,000.00 |
| Aug 31, 2024 | 125,000.00 |
| May 31, 2024 | 125,000.00 |
| Feb 29, 2024 | 409,000.00 |
| Nov 30, 2023 | 142,000.00 |
| Aug 31, 2023 | 400,000.00 |
| May 31, 2023 | 405,000.00 |
| Feb 28, 2023 | 565,000.00 |
| Nov 30, 2022 | 580,000.00 |
| Aug 31, 2022 | 576,000.00 |
| May 31, 2022 | 576,000.00 |
| Feb 28, 2022 | 637,000.00 |
| Nov 30, 2021 | 793,000.00 |
| Aug 31, 2021 | 952,000.00 |
| May 31, 2021 | 852,000.00 |
| Feb 28, 2021 | 157,000.00 |
| Nov 30, 2020 | 1.24 Mn |
API Access
CytoDyn Amortization of Deferred Charges API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortization-of-deferred-charges", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();